AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Teva Pharmaceutical Industries Ltd.

Foreign Filer Report Feb 9, 2022

7082_rns_2022-02-09_77aa9ed4-8175-4e8a-8a95-19ce63ed52fc.htm

Foreign Filer Report

Open in Viewer

Opens in native device viewer

������ ������ ������ ������ ����� ����� 2021 false

��� ������ ��������� ��"� 2 380
TEVA- PHARMACEUTICAL INDUSTRIES LTD
Corporation no: 520013954 10205
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 09/02/2022
www.isa.gov.il www.tase.co.il Reference: 2022-02-014712 Time of broadcast: 14:06 14:06

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on������ ������ ������ ������ ����� ����� 2021

Press_Release_final_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NYSE Date of revision of form structure: 30/12/2021
Address: P.O.B 3190 , Petach Tikva 49131   , Tel: 03-9148262 , Fax: 03-9267519
E-mail address: [email protected]
Previous names of reporting entity:
Name of the Signatory: Bergwerk Dov Position of Signatory in the reporting corporation: Vice President & General Counsel Name of Employer Company:
Address: Basel 5 , Petach-Tikva 4951033 Telephone: 03-9267149 Facsimile: 03-9267429 E-mail: [email protected] 1

Talk to a Data Expert

Have a question? We'll get back to you promptly.